BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 18712977)

  • 1. Methylthioadenosine phosphorylase expression in cutaneous squamous cell carcinoma.
    Alhebshi HM; Pant I; Kaur G; Hashim H; Mabruk MJ
    Asian Pac J Cancer Prev; 2008; 9(2):291-4. PubMed ID: 18712977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of p16 expression and allelic imbalance / loss of heterozygosity of 9p21 in cutaneous squamous cell carcinomas.
    Gray SE; Kay E; Leader M; Mabruk M
    J Cell Mol Med; 2006; 10(3):778-88. PubMed ID: 16989737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical determination of the P15 protein expression in cutaneous squamous cell carcinoma.
    Moad AI; Lan TM; Kaur G; Hashim H; Mabruk MJ
    J Cutan Pathol; 2009 Feb; 36(2):183-9. PubMed ID: 18564286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methylthioadenosine phosphorylase gene deletions are common in osteosarcoma.
    García-Castellano JM; Villanueva A; Healey JH; Sowers R; Cordon-Cardo C; Huvos A; Bertino JR; Meyers P; Gorlick R
    Clin Cancer Res; 2002 Mar; 8(3):782-7. PubMed ID: 11895909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Localization of a novel tumor suppressor gene loci on chromosome 9p21-22 in oral cancer.
    Nakanishi H; Wang XL; Imai FL; Kato J; Shiiba M; Miya T; Imai Y; Tanzawa H
    Anticancer Res; 1999; 19(1A):29-34. PubMed ID: 10226521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Independent Loss of Methylthioadenosine Phosphorylase (MTAP) in Primary Cutaneous T-Cell Lymphoma.
    Woollard WJ; Kalaivani NP; Jones CL; Roper C; Tung L; Lee JJ; Thomas BR; Tosi I; Ferreira S; Beyers CZ; McKenzie RCT; Butler RM; Lorenc A; Whittaker SJ; Mitchell TJ
    J Invest Dermatol; 2016 Jun; 136(6):1238-1246. PubMed ID: 26872600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Strong expression of methylthioadenosine phosphorylase (MTAP) in human colon carcinoma cells is regulated by TCF1/[beta]-catenin.
    Bataille F; Rogler G; Modes K; Poser I; Schuierer M; Dietmaier W; Ruemmele P; Mühlbauer M; Wallner S; Hellerbrand C; Bosserhoff AK
    Lab Invest; 2005 Jan; 85(1):124-36. PubMed ID: 15492751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene deletion chemoselectivity: codeletion of the genes for p16(INK4), methylthioadenosine phosphorylase, and the alpha- and beta-interferons in human pancreatic cell carcinoma lines and its implications for chemotherapy.
    Chen ZH; Zhang H; Savarese TM
    Cancer Res; 1996 Mar; 56(5):1083-90. PubMed ID: 8640765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fine-mapping loss of gene architecture at the CDKN2B (p15INK4b), CDKN2A (p14ARF, p16INK4a), and MTAP genes in head and neck squamous cell carcinoma.
    Worsham MJ; Chen KM; Tiwari N; Pals G; Schouten JP; Sethi S; Benninger MS
    Arch Otolaryngol Head Neck Surg; 2006 Apr; 132(4):409-15. PubMed ID: 16618910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Homozygous deletions of methylthioadenosine phosphorylase (MTAP) are more frequent than p16INK4A (CDKN2) homozygous deletions in primary non-small cell lung cancers (NSCLC).
    Schmid M; Malicki D; Nobori T; Rosenbach MD; Campbell K; Carson DA; Carrera CJ
    Oncogene; 1998 Nov; 17(20):2669-75. PubMed ID: 9840931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MTAP is an independent prognosis marker and the concordant loss of MTAP and p16 expression predicts short survival in non-small cell lung cancer patients.
    Su CY; Chang YC; Chan YC; Lin TC; Huang MS; Yang CJ; Hsiao M
    Eur J Surg Oncol; 2014 Sep; 40(9):1143-50. PubMed ID: 24969958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of FHIT allelic imbalance/loss of heterozygosity and FHIT expression in cutaneous squamous cell carcinomas.
    Gray SE; Kay E; Leader M; Mabruk M
    J Cutan Pathol; 2008 Sep; 35(9):816-25. PubMed ID: 18494825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of Chr9p21 genes CDKN2B (p15(INK4b)), CDKN2A (p16(INK4a), p14(ARF)) and MTAP in human atherosclerotic plaque.
    Holdt LM; Sass K; Gäbel G; Bergert H; Thiery J; Teupser D
    Atherosclerosis; 2011 Feb; 214(2):264-70. PubMed ID: 20637465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of methylthioadenosine phosphorylase cDNA in p16-, MTAP- malignant cells: restoration of methylthioadenosine phosphorylase-dependent salvage pathways and alterations of sensitivity to inhibitors of purine de novo synthesis.
    Chen ZH; Olopade OI; Savarese TM
    Mol Pharmacol; 1997 Nov; 52(5):903-11. PubMed ID: 9351982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Promoter-hypermethylation is causing functional relevant downregulation of methylthioadenosine phosphorylase (MTAP) expression in hepatocellular carcinoma.
    Hellerbrand C; Mühlbauer M; Wallner S; Schuierer M; Behrmann I; Bataille F; Weiss T; Schölmerich J; Bosserhoff AK
    Carcinogenesis; 2006 Jan; 27(1):64-72. PubMed ID: 16081515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genomic cloning of methylthioadenosine phosphorylase: a purine metabolic enzyme deficient in multiple different cancers.
    Nobori T; Takabayashi K; Tran P; Orvis L; Batova A; Yu AL; Carson DA
    Proc Natl Acad Sci U S A; 1996 Jun; 93(12):6203-8. PubMed ID: 8650244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular genetic analysis of the BRCA2 tumor suppressor gene region in cutaneous squamous cell carcinomas.
    Gray SE; Kay E; Leader M; Mabruk M
    J Cutan Pathol; 2008 Jan; 35(1):1-9. PubMed ID: 18095987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tissue microarray analysis of methylthioadenosine phosphorylase protein expression in melanocytic skin tumors.
    Wild PJ; Meyer S; Bataille F; Woenckhaus M; Ameres M; Vogt T; Landthaler M; Pauer A; Klinkhammer-Schalke M; Hofstaedter F; Bosserhoff AK
    Arch Dermatol; 2006 Apr; 142(4):471-6. PubMed ID: 16618867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of methylthioadenosin phosphorylase (MTAP) expression in malignant melanoma.
    Behrmann I; Wallner S; Komyod W; Heinrich PC; Schuierer M; Buettner R; Bosserhoff AK
    Am J Pathol; 2003 Aug; 163(2):683-90. PubMed ID: 12875987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methylthioadenosine phosphorylase as target for chemoselective treatment of T-cell acute lymphoblastic leukemic cells.
    Efferth T; Miyachi H; Drexler HG; Gebhart E
    Blood Cells Mol Dis; 2002; 28(1):47-56. PubMed ID: 11987241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.